Nchi: Australia
Lugha: Kiingereza
Chanzo: Department of Health (Therapeutic Goods Administration)
methylene blue, Quantity: 50 mg
Phebra Pty Ltd
Methylene blue
Injection, solution
Excipient Ingredients: water for injections; hydrochloric acid; sodium hydroxide
Intravenous
10 vials
(S4) Prescription Only Medicine
Methylene Blue Injection USP is indicated: for the treatment of drug-induced methaemoglobinaemia; for the treatment of idiopathic methaemoglobinaemia (in which structural abnormality of haemoglobin is not present); as a bacteriological strain as a dye in diagnostic procedures such as fistula detection; for the delineation of certain body tissues during surgery.
Visual Identification: clear blue coloured solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Licence status A
2014-10-01
METHYLENE BLUE INJECTION 50 MG IN 5 ML CONTAINS 50 MG/ 5 ML METHYLENE BLUE TRIHYDRATE CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Methylene Blue Injection. It does not contain all the available information. It does not take the place of talking to your doctor. All medicines have risks and benefits . Your doctor has weighed the risks of you being given Methylene Blue Injection against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT BEING GIVEN THIS MEDICINE, ASK YOUR DOCTOR. KEEP THIS LEAFLET IN A SAFE PLACE . You may need to read it again. WHAT METHYLENE BLUE INJECTION IS USED FOR Methylene Blue Injection is used to treat abnormal blood pigment levels. These abnormal blood pigments do not carry oxygen properly. This medicine belongs to a group of medicines called dyes. Methylene Blue Injection is also used: • to stain bacteria to make them easier to see • as a visible dye to help in the diagnosis of a number of conditions • as a stain to dye certain body tissues during surgery. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed it for another reason. Methylene Blue Injection is not recommended for long-term use. This medicine is only available with a doctor’s prescription. BEFORE YOU ARE GIVEN METHYLENE BLUE INJECTION _WHEN YOU MUST NOT BE GIVEN _ _IT _ YOU SHOULD NOT BE GIVEN METHYLENE BLUE INJECTION IF YOU HAVE AN ALLERGY TO: • any medicine containing methylene blue • any other dyes. Some of the symptoms of an allergic reaction may include: • shortness of breath • wheezing or difficulty breathing • swelling of the face, lips, tongue or other parts of the body • rash, itching or hives on the skin. _ _ YOU SHOULD NOT BE GIVEN THIS MEDICINE IF YOU HAVE GLUCOSE-6- PHOSPHATE DEHYDROGENASE DEFICIENCY. This is an inherited condition. YOU SHOULD NOT BE GIVEN THIS MEDICINE IF YOU HAVE KIDNEY PROBLEMS. YOU SHOULD NOT BE GIVEN THIS MEDICINE Soma hati kamili
PRODUCT INFORMATION Australian Product Information - Methylene Blue Injection Page 1 of 8 Version 02 METHYLENE BLUE INJECTION (METHYLENE BLUE) 1 NAME OF THE MEDICINE Methylene blue (also known as methylthioninium chloride) 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Methylene blue is a dark blue or dark green crystalline powder with a metallic sheen. It is soluble in water, alcohol and chloroform. Methylene Blue Injection is a sterile solution of methylene blue trihydrate 50 mg For the full list of excipients, see Section 6.1 List of Excipients. 3 PHARMACEUTICAL FORM Methylene Blue Injection is a sterile solution for oral/intravenous use. The pH of the solution ranges between 3.0 and 4.5. 4 CLINICAL PARTICULARS 4.1 T HERAPEUTIC INDICATIONS Methylene Blue Injection is indicated_: _ • for the treatment of drug-induced methaemoglobinaemia • for the treatment of idiopathic methaemoglobinaemia (in which a structural abnormality of haemoglobin is not present) • as a bacteriological stain • as a dye in diagnostic procedures such as fistula detection • for the delineation of certain body tissues during surgery. 4.2 D OSE AND METHOD OF ADMINISTRATION Methylene Blue Injection may be administered orally or by intravenous injection. In the treatment of acute methaemoglobinaemia, the intravenous route of administration is usually preferred because it provides a more rapid onset of effect. ADULTS AND CHILDREN In the treatment of methaemoglobinaemia, methylene blue is administered intravenously as a 1% solution in doses of 1 mg to 2 mg per kg bodyweight injected over a period of several minutes. A repeat dose may be given after one hour if required. A maximum dose of 7 mg/kg bodyweight is recommended. The use of methylene blue is not recommended in infants under 4 months of age. A dose of 5 mg/kg diluted in 500 mL of glucose 5% infused over 1 hour has been used successfully to stain and identify the parathyroid glands. PRODUCT INFORMATION METHYLENE BLUE INJECTION Australian Product Information - Methylene Blue Injectio Soma hati kamili